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MANAGING THE TRANSITION
TO ADULTHOOD BEGINS IN CHILDHOOD
Transition into the adult health care system is crucial for
patients with congenital heart disease (CHD), as well as for
adolescents with many other chronic conditions. Indeed,
“arranging efficient and caring transfer for adolescents from
pediatric to adult care (is). . .one of the great challenges
facing pediatrics—and indeed the health care services—in
the coming century” (1). Centers that care for adolescents
and young adults with CHD need to develop structured
plans for the transfer of care from the department of
pediatric cardiology to that of adult cardiology. A compre-
hensive program taking a developmental approach begin-
ning in childhood and adolescence should achieve better
results than programs that focus only on the transfer to adult
care at a specified age.
Currently, sufficient empirical data are not available to
support the identification of “best practices” regarding
transition in this patient group. However, descriptive and
qualitative studies have indicated that the key elements of an
effective transition program include:
1. A policy on timing of transfer to adult care (age 18 or
upon leaving school is recommended by many, with
some flexibility);
2. A preparation period and education program that focus
on a set of skills that enables young people and their
families to function in an adult clinic (e.g., understand-
ing the disease, treatment rationale, and source of symp-
toms; recognizing deterioration and taking appropriate
action; learning how to seek help from health profes-
sionals and how to operate within the medical system);
3. A coordinated transfer process (including a detailed
written plan and pretransfer visit to the adult clinic, with
an introduction to the adult provider and with a desig-
nated coordinator such as a clinic nurse);
4. An interested and capable ACHD regional center that is
at least equivalent in quality to that of the pediatric
source the patient is leaving (see subsequent discussion);
5. Administrative support; and
6. Primary care involvement.
The published data also suggest that transitions are more
successful in health care settings where:
1. The preparation for transition begins before adolescence,
and transition is seen as an essential component of
high-quality health care.
2. There is a formal transition program.
3. Young people are not transferred to adult services until
they have the necessary skills to function in an adult
service and have finished growth and puberty.
4. There is an identified person on both the pediatric and
adult teams who has responsibility for transition arrange-
ments (usually nurse specialists).
5. Management links are developed between the pediatric
and adult systems, and financial and contracting issues
are worked out in detail and put in writing.
6. The evaluation of transition arrangements is undertaken
as part of a continuous quality improvement process.
7. Transfer is planned and carried out during a period of
medical stability; and
8. After transfer, there should be ongoing consultation with
the referring pediatric cardiologist.
Sometimes parents need counseling and support to let go of
their adult offspring. Adolescents need support and encour-
agement to begin making decisions, maximizing their
strengths and abilities, and taking control of their lives.
Support groups for patients and/or parents may provide a
reality-based interchange of shared issues. Large referral
institutions can provide direct support group access, but
patients in other areas may be best served by Internet
support groups (e.g., CACHnet [www.cachnet.org], Chil-
dren’s Health Information Network [http://tchin.org]) and
newsletters.
Factors such as a lack of symptoms and strong attachment
to a pediatric cardiology program may result in the failure to
transfer successfully to ACHD services. Many adults with
CHD have the impression that the operation performed in
childhood was a “cure.” They may be unaware of their
prognosis and believe that regular cardiac follow-up is
unnecessary. Comprehensive, individualized education re-
garding their cardiac condition and health care needs, as
well as a “road map” regarding life-style implications, can
help patients to achieve independence. In addition to
routine health care recommendations, the health education
objectives should be specific for young adults with CHD
and should include specific information on diagnoses and
operations, medications and their side effects, endocarditis
prophylaxis, exercise prescription, contraception and family
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planning, career planning and resources, insurance, guide-
lines for frequency of medical follow-up, and dental care.
Education regarding symptoms that could be serious, such
as arrhythmias, is essential. This information should be
summarized in a “health passport” that can be held in the
patient’s possession.
The timing and manner of communicating with patients
is very important. Presenting an overwhelming amount of
information in a single session should be avoided, especially
during early transition visits. The potential to throw the
patient into despair or denial exists and could lead to
avoidance of much-needed visits to a medical center in the
future. Discussions should proceed at a rate commensurate
with the psychosocial development and circumstances of the
patient. Traditionally, many pediatricians have continued to
care for adults with developmental disabilities, but provision
for this group needs to be part of the planning for adult care.
Children with CHD should be given the expectation that
they will grow up to be healthy and able to work. Questions
like “what do you want to be when you grow up?” should be
asked by pediatric primary and specialty care providers,
starting in early childhood (;age 4). In their transition to
adulthood, adolescents should prepare for economic inde-
pendence and vocational competence. Although the major-
ity of patients with postoperative CHD are functionally
normal, the label of heart disease or a mild disability can
heighten these developmental challenges. The possibility of
further surgery can also impede long-term planning. Ado-
lescents should be encouraged to achieve higher education
and skills necessary for employment in occupations that are
reasonable in relation to their work capacity. Vocational
guidance should be emphasized in early adolescence (ages
13–15), as training and acquisition of special knowledge and
skills are important to the young adult if he or she is going
to compete with other applicants.
UNIQUE MEDICAL ISSUES
Cyanotic patients. Cyanotic patients with CHD should be
seen regularly at a regional ACHD center. Their physicians
should be aware of special issues in their care. There are
medical problems extrinsic to the cardiovascular system,
which can cause significant morbidity and mortality in such
patients. Severe cyanosis leads to marked erythrocytosis and,
frequently, to low platelet counts (.100,000) (2), which,
fortunately, seldom lead to significant bleeding. The ab-
sence of erythrocytosis (e.g., hemoglobin .17.0 g/dl) in
such patients should raise concern about a “relative anemia”
and its cause and implications. Excessive erythrocytosis
adversely affects whole blood viscosity, but this problem is
normally not associated with symptoms until the hematocrit
levels are at least .60% to 65%. The only valid indication
for therapeutic phlebotomy is to alleviate symptoms of
hyperviscosity. Many patients undergo phlebotomy by pri-
mary care physicians to reduce their hematocrit. This
practice should be discouraged; phlebotomy should be
undertaken only in a center that manages cyanotic patients.
When blood is removed, volume replacement with normal
saline is recommended. Failure to follow this procedure can
be associated with hypotension, increased right to left
shunting, stroke, seizures, and death, especially in patients
with pulmonary vascular disease. Multiple phlebotomies
result in iron depletion, which is disadvantageous and has an
independent negative effect on exercise performance. Iron
deficiency is associated with impaired small-vessel blood
flow and an increase in the risk of reversible ischemic
neurologic deficits and stroke (3). When iron deficiency
does occur, it should be treated.
Cyanotic patients frequently have hyperuricemia with
arthralgia, gouty arthritis, and overt tophaceous deposits of
urate. These abnormalities are secondary to low uric acid
fractional excretion, not to urate overproduction (4). There-
fore, hyperuricemia is a marker of abnormal renal function,
which can be a problem in patients with long-standing
cyanotic heart disease. Acute gouty arthritis responds to
colchicine; special care should be taken to avoid dehydration
that could occur with vomiting and diarrhea, which would
require cessation of drug therapy. Allopurinol, with or
without a uricosuric agent, is considered for symptomatic
hyperuricemia refractory to other medications (2).
Pulmonary vasodilator therapy, specifically prostacyclin,
has been used successfully in a small number of patients
with Eisenmenger syndrome, serving as a bridge to repair in
a few. The role for pulmonary vasodilators is being studied
intensively.
Noncardiac surgery. Adults with moderate and complex
CHD (see Tables 4 and 5 of Task Force #1) who require
noncardiac surgery have special needs to be addressed by the
surgical and anesthesia team. Ideally, operations in patients
with complex CHD should be performed at a regional
ACHD center with physicians experienced in the care of
these individuals and with the consultation of cardiologists
trained in this discipline (5). Frequently encountered man-
agement issues include cessation of anticoagulant agents and
use of antibiotics for endocarditis prophylaxis (6). Important
considerations for anesthetic management include the func-
tional class of the patient, ventricular function, persistent
shunts, valvular disease, arrhythmias, erythrocytosis, pulmo-
nary disease, and pulmonary vascular disease.
Risk factors that help predict the possibility of perioper-
ative risk include cyanosis (p 5 0.002), treatment for
congestive heart failure (p , 0.001), poor general health
(p , 0.001), and younger age (p 5 0.03) (7). Patients with
pulmonary hypertension probably have a higher complica-
tion rate (15%) than patients without pulmonary hyperten-
sion (4.7%; p 5 0.08). Procedures performed on the
respiratory and nervous systems seem to be associated with
the most complications.
The extent of preoperative evaluation varies depending on
the complexity of the heart disease. A complete understand-
ing of the patient’s underlying anatomy is necessary. A
preoperative echocardiogram and, rarely, cardiac catheter-
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ization may be indicated when recent data are not available.
Stress studies may be indicated to exclude coexistent coro-
nary artery disease in older adults. Estimates of pulmonary
hypertension are useful, because some patients are at in-
creased risk for Eisenmenger syndrome (8). If pulmonary
disease exists, preoperative pulmonary function tests may be
necessary to determine its severity and to estimate the need
for postoperative ventilation. Preoperative laboratory testing
in cyanotic patients should include an evaluation of the
hematologic system (5), including coagulation and platelet
abnormalities (9). Isovolumetric phlebotomy to a hemato-
crit ,65% has been recommended to improve hemostasis.
Practices vary among centers, and further study is war-
ranted.
In patients receiving long-term anticoagulation, protocols
for stopping warfarin, by using perioperative heparin, and
restarting warfarin should be developed and coordinated
with the surgical and dental team to minimize blood loss
and prevent complications. The decision for invasive mon-
itoring, such as intra-arterial catheters and/or central venous
catheters, should be based on the magnitude of the opera-
tion and the specific nature of the cardiac defect. The
decision to monitor invasively should be weighed against the
risk of complications. In all cyanotic patients, meticulous
attention should be paid to all intravenous lines to ensure
freedom from air bubbles, which may cause systemic air
embolism. Intraoperative transesophageal echocardiography
may be useful for continuous monitoring of ventricular
function and for estimating preload conditions. The choice
of anesthetic agent depends on the severity of the cardiac
disease and other co-morbidities and must be tailored to the
operation. Avoidance of myocardial depression and hypo-
volemia is emphasized. Epidural anesthesia can provide
excellent operative and postoperative analgesia, with mini-
mal cardiovascular side effects in select patients.
CONTRACEPTION AND PREGNANCY IN WOMEN
Contraception. All patients must be well informed of the
risks of pregnancy associated with their condition and the
available options to avoid pregnancy when desired. The
risks of pregnancy vary widely among the specific types of
CHD (see subsequent discussion). There are no systematic
outcome data on the safety of contraceptive methods in
women with CHD. The choice of contraceptive method is
usually made by the patient. However, it is the responsibility
of the physician to provide thorough counseling about the
risk of unplanned pregnancy in the case of non-compliance,
poor acceptance or failure of the contraceptive technique,
and any risk associated with the specific method including
infective and thromboembolic complications. In considering
surgical sterilization because of high risk, the patient should
be fully informed of the potential for medical advances that
may permit future pregnancy at lower risk.
Pregnancy risk. Pregnancy in women with CHD not
complicated by Eisenmenger syndrome is associated with a
low mortality (10–12). However, potential risk factors for
maternal morbidity include poor maternal functional class,
poorly controlled arrhythmias, heart failure, cyanosis, sig-
nificant left heart obstruction, and a history of cerebral
ischemia (10–14). Cyanosis is a risk factor for fetal and
neonatal complications (10–12,14). On the basis of these
risk factors, patients can be stratified into low-,
intermediate-, or high-risk categories (12). An absence of
these risk factors would generally place patients into a
low-risk category. The highest risk is associated with
Eisenmenger syndrome, in which postnatal maternal mor-
tality can exceed 50%. Because much of the current data are
based on retrospective case series from tertiary care institu-
tions, one should exercise caution in risk stratification of
pregnant women with uncommon conditions such as Mus-
tard/Senning or in those who have had a Fontan procedure
(15–17). Patients with these lesions or procedures should be
placed in the intermediate-risk category until additional
data become available. The risk of in vitro fertilization for
surrogate pregnancy in high-risk women with CHD has not
been defined. Medical or surgical termination of pregnancy
in intermediate or high-risk patients requires careful mon-
itoring, and preferably it should be done in a regional
ACHD center.
Special needs of pregnancy. Women with heart disease
who are at intermediate or high risk or an uncertain level of
risk for complications should be managed in a high-risk
perinatal unit by a multidisciplinary team including an
obstetrician, cardiologist, anesthesiologist, and pediatrician.
The team should meet early in the patient’s pregnancy to
review the cardiac lesion, anticipated effects of pregnancy,
and potential problems and to develop a management plan.
Specific issues that need to be considered include the timing
and mode of delivery, the type of anesthesia to be used, the
need for hemodynamic monitoring before and after delivery
and the use of antibiotic prophylaxis. Women with heart
disease in the low-risk group can usually be managed in a
community hospital setting.
Risk of recurrence of CHD in offspring. Genetic coun-
seling regarding etiology, inheritance, recurrence risk, and
prenatal diagnosis options should be made available to all
patients with CHD. It is important to obtain the patient’s
prenatal and postnatal history, including maternal exposure
to teratogens, as well as a detailed family history, and to
perform a thorough examination looking for congenital
abnormalities (18).
In all women contemplating pregnancy, exposure to
teratogens should be investigated; in some cases, finding an
alternative medication will be necessary. Angiotensin-
converting enzyme inhibitors and angiotensin II receptor
antagonists should not be used during pregnancy. Medica-
tions for which substitution should be considered include
warfarin and amiodarone. No medications, including over-
the-counter preparations, should be taken during pregnancy
without physician approval. Preconception consumption of
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multivitamins including folic acid decreases the incidence of
CHD (19).
Knowledge of the genetic basis of CHD is expanding
rapidly. The role of genetic testing is evolving, and genetic
counseling should be made available. The recurrence rate of
CHD in offspring is variable, ranging from 3% to 50%. A
higher recurrence risk when the mother rather than the
father is affected has raised the possibility of mitochondrial
inheritance in some patients (20). Diseases with a single
gene disorder and/or chromosomal abnormalities are asso-
ciated with a high recurrence rate. In Marfan, Noonan, and
Holt-Oram syndromes, there is a 50% risk of recurrence.
Fetal echocardiography at 16 to 18 weeks gestation
should be available to all patients with CHD. Chorionic
villus sampling or amniocentesis may be useful after discus-
sion of the potential risks and benefits.
EXERCISE TOLERANCE AND REHABILITATION
Exercise data. The ability to exercise is one measure of
quality of life, and it is used to assess the effect of disease,
the results of treatment, and the ability to tolerate the stress
associated with pregnancy or needed surgery. There have
been numerous studies of exercise tolerance in children and
adolescents with CHD but very few studies in adults.
Adults with pulmonary stenosis have well-preserved but
still subnormal exercise tolerance. Exercise tolerance for
adults with aortic stenosis or a ventricular septal defect
(VSD) is subnormal and even less than that for adults with
pulmonary stenosis. Rather surprisingly, two investigators
have reported that exercise tolerance is subnormal for
patients who had repair of an atrial septal defect (ASD).
Reybrouck et al. (21) have demonstrated that the age when
closure of an ASD is performed influences postoperative
exercise tolerance. Adults with complex conditions, such as
Ebstein’s anomaly or a single ventricle, have a markedly
abnormal exercise tolerance. There are few studies of exer-
cise tolerance of adults with transposition of the great
arteries, pulmonary atresia with or without VSD, and other
complex conditions. However, studies of children and
adolescents with these defects show subnormal exercise
tolerance, and it is assumed that exercise tolerance would be
no greater in adults with similar defects.
Recommendations for athletic participation for patients
with CHD were published in the 26th Bethesda Confer-
ence (22) and are the best consensus data available.
Exercise training and rehabilitation. Because adults with
CHD have subnormal exercise tolerance, an obvious ques-
tion is whether physical conditioning reduces symptoms and
improves exercise tolerance and quality and/or length of life.
These issues have not been studied. There are numerous
studies validating the benefits of exercise for healthy adults
and those with coronary artery disease (23). There have
been several studies of the utility of exercise programs for
children with CHD (24,25). Despite major design prob-
lems, these studies demonstrate that a structured rehabili-
tation program can increase exercise efficiency. Improved
exercise performance (i.e., maximal oxygen consumption)
was not demonstrated in most studies. Because all of these
studies were small, a survival benefit could not be demon-
strated. An alternative to a costly structured rehabilitation
program is a simple home program of physical rehabilita-
tion, which was successful in one study (26). The efficacy
and safety of a structured exercise rehabilitation program for
adults with CHD are unknown. Issues that require further
study in adult patients include the efficacy of such a program
in improving fitness and aerobic capacity, the safety of such
programs, and the interaction between congenital and
acquired heart disease.
PSYCHOSOCIAL ISSUES
Only recently have patients with complex CHD survived
into adult life in large numbers. Their survival creates hope
that continuing advances will help them maintain both
quality of life and longevity. However, patients may expe-
rience despair due to their awareness of residual morbidities
and the knowledge of possible or probable early mortality,
or limitations in their social lives and educational or occu-
pational attainment. Healthy psychosocial functioning de-
pends on their ability to balance hope and despair. Adults
with CHD must also confront both CHD-specific and
general developmental tasks. Psychosocial issues may be
affected by lesion severity (simple vs. complex), visibility
(e.g., cyanosis), and functional disability (27).
Life-span development and CHD. Table 1 is a proposed
model outlining developmental tasks faced by individuals
with CHD, beginning in adolescence; this model could be
tested in future studies.
Physical development. Adults with CHD may struggle
with physical appearance (e.g., scars, smaller body size,
cyanosis, clubbing), physical limitations, and acute or grad-
ual decreases in physical functioning (28–30). Physical
decline may be difficult to deal with, as peers are often less
able to empathize with these changes.
Social and family relations. Adults with CHD are less
likely to be married or cohabiting or to have children and are
more likely to live with their parents, as compared with
healthy peers (31,32). These differences may reflect life-style
decisions made based on beliefs or knowledge regarding
shortened life-expectancy, concerns about pregnancy risks,
economic constraints, or the need for social support (33,34).
Patients limiting themselves due to misinformation need
counseling. Difficulty discussing CHD issues with family or
friends is common among adolescents and young adults
with CHD, especially among patients whose parents rarely
discussed their own disease (35). Patients and their families
may need assistance in finding a balance between indepen-
dence and interdependence that optimizes the psychosocial
and physical health of the patient with CHD. Adolescent
and young adult patients, in particular, may need assistance
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in ways to educate their peers regarding CHD and to
maintain a peer network.
Emotional health. Although most adolescents and adults
with CHD appear to be free of psychopathology, there are
too few studies to draw conclusions about the emotional
health of this group of patients. Results of comparisons of
emotional adjustment between patients with CHD and
healthy peers have been mixed. One study found that when
items likely reflecting CHD symptoms (e.g., dizziness) were
removed from analyses, group differences were no longer
significant (36).
In patients with acquired heart disease, depression and
anxiety are linked to an increased risk of cardiac and
all-cause mortality and sudden cardiac death (37–40).
Given the high prevalence of arrhythmias with complex
CHD, this potential relationship should be examined.
Twenty percent of all adults have a psychiatric disorder (41).
Even if adults with CHD were not at increased risk of
psychopathologic conditions, one in five patients would be
expected to have a significant mental health problem.
Surgery, hospital admission, invasive medical procedures,
and even routine appointments may trigger emotional
distress, especially in individuals with a pre-existing emo-
tional disorder.
Medical issues. Only one half to three fourths of adults
with CHD can correctly state or describe their diagnosis
(42–44). Given complex anatomies and surgical repairs, it
may not be possible for all patients with CHD to have
precise anatomic knowledge, but aids such as a “health
passport” may be helpful in providing the patient with the
most important information.
Adults with CHD may have difficulty coping with
repeated hospital admissions, operations, and other painful
medical procedures. They underwent cardiac surgery during
an era of inadequate pain control (45), which may result in
centrally mediated pain sensitization for them (46). Patients
with CHD should receive education about pain and its
management and receive optimal medication and manage-
ment of procedure-related pain. Health care personnel must
also be informed of the special issues related to pain
management in this group.
Health behaviors. Poor knowledge of behaviors related to
endocarditis and its prevention are common (42–44,47).
Unrealistic fears (e.g., fear of damaging the heart or having
a cardiac arrest) may be a factor in their lack of activity.
However, some patients who have been advised against
heavy exercise will engage in it anyway (e.g., by engaging in
contact sports) (30). Although consensus (27) and common
sense suggest that regular medical follow-up, as compared
with nonattendance, should result in better outcomes, proof
is lacking. Patients’ beliefs regarding treatment effectiveness
(e.g., medication) or health behaviors (e.g., regular medical
appointments) are a significant predictor of compliance and
should be assessed.
Personality and identity. Establishing one’s identity, bal-
ancing independence with interdependence, and accepting
death are tasks of normal development. In addition, adults
with CHD must incorporate their condition into their
identity, deal with a lack of control over changes in physical
functioning, resolve the loss or disruption of typical devel-
opmental achievements (e.g., surgery may result in loss of an
academic year), and face the prospect of premature mortal-
ity. These issues must be faced repeatedly throughout
adulthood and may necessitate counseling.
Screening and prevention. Routine screening for psycho-
social or physical problems is not without risk (48–50) and
should be undertaken only if there are accurate measures,
appropriate mechanisms to provide feedback, and appropriate
resources for treatment. Because validated CHD-specific mea-
sures do not exist, measures of perceived risk of CHD
complications and health behaviors should be developed.
Treatment issues. Although there are validated psychoso-
cial and pharmacologic treatments for many psychological
disorders (41), treatment effectiveness could be enhanced if
interventions are adapted to deal with CHD-specific issues.
Treatments specific to CHD should focus on enhancing
knowledge, modifying maladaptive beliefs, and dealing with
periods of transition and acute stress.
The level of treatment intensity could be tailored to the
severity of the problem, ranging from self-help materials for
those with mild or moderate problems to individual or
group therapy for those with severe problems. Creative
solutions that offer individual counseling for patients at a
distance from a regional ACHD center are needed. As
interventions are developed, it is crucial to document pro-
cedures and evaluate effectiveness so centers can share and
build on each other’s experiences.
RECOMMENDATIONS
Transition to Adult Life
c Structured plans should be developed to transition pa-
tients from pediatric to adult CHD care. Transition to a
regional ACHD center can be difficult for patients, and
the presentation of an overwhelming amount of informa-
tion in a single session should be avoided. Discussions
should proceed at a rate commensurate with the psycho-
social development and circumstances of the patient.
c Individual patient education regarding his/her diagnosis
and specific health behaviors should be a priority.
c Important historic information, including comprehensive
diagnostic data, procedures, operations, and medications,
should be kept by the patient as a summary of past and
present important health issues. The American College of
Cardiology should support development of a health care
“passport,” which would be useful for all patients with
CHD and their health care providers.
c A continuum of vocational assessment beginning in
childhood should be available for patients with CHD and
should be continued during the developmental, adoles-
cent, and young adult years.
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Noncardiac Surgery
c Ideally, noncardiac operations on patients with complex
CHD should be performed at a regional ACHD center
with the consultation of an anesthesiologist with experi-
ence in CHD, particularly for more complex surgery or
for patients with adverse risk factors that include poor
functional class, pulmonary hypertension, CHF, and cy-
anosis.
Reproductive Issues
c Contraceptive counseling must be available, when appro-
priate, to all patients with CHD.
c A multidisciplinary team at a regional ACHD center is
needed for pregnancy and delivery, as well as for the
management of indeterminate-, intermediate-, or high-
risk patients.
c The recurrence risk of CHD is highly variable and should
be discussed prospectively with all patients. Genetic
counseling should be made available through regional
ACHD centers.
Exercise and Rehabilitation
c Guidance for athletic participation for patients with
CHD should be in accordance with the published recom-
mendations of the 26th Bethesda Conference report,
which represents the best consensus data available.
c The efficacy and safety of exercise rehabilitation programs
in adults with CHD have not been studied, and research
in this area should be supported.
Psychosocial Issues
c The emotional health of adults with CHD should be a
priority in the overall care of this patient population.
Appropriate screening and referral sources for treatment
should be available at all regional ACHD centers.
c Tools for screening of psychosocial problems in this
population should be developed and tested.
c Data should be developed to assess the impact of regular
follow-up care on the long-term physical and psychosocial
health of adults with CHD.
c Available professionals and facilities for the treatment of
psychological disorders are scarce, and creative solutions
for counseling patients in groups and/or those at a
distance from home should be developed.
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INTRODUCTION
The expansion of the population of adults with congenital
heart disease (CHD) and the increasing survival of patients
with complex disease into adulthood have heightened the
need for specifically trained individuals who can provide
comprehensive outpatient and in-patient care and consul-
tative services to these patients (1–3). In addition, such
individuals should have the educational background neces-
sary for successful academic careers in order to advance
knowledge and educate other providers. At present, only a
few specialists in the U.S. have been specifically trained for
this role. Most adult congenital heart disease (ACHD)
patients are followed by adult cardiologists who have not
had much training in the diagnosis or management of CHD
or by pediatric cardiologists who have had little or no
experience or training in comprehensive adult care. Adult
cardiologists often unofficially consult with pediatric cardi-
ologists to plan management, but uncompensated time and
medico-legal risks have made this practice increasingly
difficult for pediatric cardiologists. Pediatric cardiologists
may effectively co-manage adult patients with an internist or
family medicine practitioner, but they cannot provide the
full complement of in-patient or invasive services that may
be needed. In some cases, adult and pediatric cardiologists
follow ACHD patients in a joint clinic. These practices vary
considerably depending on patient volume, institutional
resources, and physician interest.
The routes by which adult and pediatric cardiologists in
this field arrived at their level of expertise are varied. Many,
if not most, adult cardiologists have had on-the-job training
which provided them with an opportunity to learn, in an
environment of collaboration, from pediatric cardiologists
and cardiac surgeons. Many pediatric cardiologists have
become increasingly involved with adults with CHD as
their pediatric patients have aged. Although ACHD pa-
tients will continue to rely on these traditionally trained
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